Gain Share Price

Gain Share Price

NASDAQ: GANX | Micro Cap | Healthcare
$1.09
-$0.08 (-7.23%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Gain Stock Performance

Open
$1.21
Prev. Close
$1.18
Circuit Range
N/A
Day Range
$1.09 - $1.21
Year Range
$0.94 - $4.33
Volume
25,406
Average Traded
$1.15

Gain Share Price Today

As of 19 November 2026, Gain Therapeutics, Inc.'s share price is $1.09. The stock opened at $1.21, compared to its previous close of $1.18. During today's trading session, Gain Therapeutics, Inc.'s share price traded between $1.09 and $1.21, with an average price of $1.15. Over the past 52 weeks, the stock has recorded a high of $4.33 and a low of $0.94. In terms of performance, Gain Therapeutics, Inc.'s share price has declined by 44.95% over the last six months and is down 68.81% on a year-on-year basis.

Gain Share Price Chart

Line chart of the Gain price trend over the selected period. The price fell overall, ranging from 1.09 to 1.23, ending at 1.09.
$1.09$1.21
L
Show Current Price
H

Gain Stock Fundamentals & Key Indicators

Market Cap
$35.94M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.40
Revenue (TTM)
$0.00
Return On Equity (TTM)
-177.15%
Profit Margin
N/A
Debt to Equity
0.03
Quarterly Earnings Growth YoY
30.40%

Gain Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.54-$5.61-$4.68-$3.16
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-23.57%16.58%32.48%

Gain Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.13$0.06$0.00$0.00
Net Profit-$17.59-$22.27-$20.41-$20.16
Net Profit Margin-13530.77%-37116.67%N/AN/A
Income ChangeN/A-26.61%8.35%1.22%

Gain Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.580.520.833.01
Current Assets22.2411.617.7821.09
Total Assets22.8212.1218.6124.1
Non Current Liabilities0.90.871.081.09
Current Liabilities3.353.914.954.13
Total Liabilities4.254.786.035.22
Shareholders' Equity18.567.3412.5818.88

Gain Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-18.47-18.87-18.87-14.69
Investing0.04.9810.22-14.77
Financing28.4513.0112.64-0.08

About Gain

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Gain Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.18
$1.09
-3.96%
Oct 2026
$1.73
$1.14
-34.77%
Sep 2026
$1.81
$1.74
-6.20%
Aug 2026
$1.68
$1.85
+10.42%
Jul 2026
$2.04
$1.68
-17.20%
Jun 2026
$1.96
$2.03
+2.47%
May 2026
$1.83
$1.98
+4.76%
Apr 2026
$1.95
$1.89
-2.07%
Mar 2026
$2.54
$1.93
-26.05%
Feb 2026
$1.85
$2.61
+44.20%
Jan 2026
$3.20
$1.81
-43.88%
Dec 2025
$3.40
$3.23
-7.73%

Gain Share Price FAQs